Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Femtogenix patents new antibacterials

March 27, 2020

Ascletis publishes data from clinical study of danoprevir for COVID-19

March 25, 2020

Novartis divulges new compounds for herpesvirus infection

March 25, 2020

First patients enrolled in RECOVERY study evaluating potential COVID-19 treatments

March 25, 2020

Ciclesonide shows antiviral activity against SARS-CoV-2

March 25, 2020

Biomedical R&D takes hit as university labs, trials shut down due to COVID-19

March 24, 2020

FDA approves phase III study of Actemra in patients with severe COVID-19 pneumonia

March 24, 2020

Sorrento develops Covidtrap protein for potential prevention and treatment COVID-19

March 24, 2020

Celltrion announces key milestones in COVID-19 efforts

March 23, 2020

New compounds for HBV infection presented by Assembly Biosciences

March 23, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...